JHVEPhoto | BigStock.com
The U.S. Government Accountability Office (GAO) has recommended that Congress consider expanding the five-year limit on conditional approval of animal drugs by the U.S. Food and Drug Administration (FDA).
GAO urges expansion of FDA’s limit on conditional approval for animal drugs
The U.S. Government Accountability Office (GAO) has recommended that Congress consider expanding the five-year limit on conditional approval of animal drugs by the U.S. Food and Drug Administration (FDA).
